You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1549 Results
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
New Drug Funding Program
    Daratumumab in Combination with a Bortezomib-Based Regimen for Newly Diagnosed Transplant Ineligible Multiple Myeloma
ODB - General Benefit
    cyclophosphamide - oral tablets
ODB - General Benefit
    dexamethasone
Mar 2026
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
New Drug Funding Program
    Daratumumab in Combination with a Bortezomib-Based Regimen for Newly Diagnosed Transplant Ineligible Multiple Myeloma
ODB - General Benefit
    cyclophosphamide - oral tablets
ODB - General Benefit
    dexamethasone
Mar 2026
Regimen
Cancer Type:
Head and Neck, 
Nasopharynx
Intent: Palliative
Apr 2026
Regimen
Cancer Type:
Head and Neck, 
Nasopharynx
Intent: Palliative
Apr 2026
Regimen
Cancer Type:
Skin, 
Squamous Cell
Intent: Adjuvant, Curative
Apr 2026
Ce carrefour contient des outils et des ressources destinés aux fournisseurs de soins primaires, aux radiologistes et aux autres fournisseurs de...
The ColonCancerCheck Resource Hub is temporarily unavailable.
Le centre de ressources ContrôleCancerColorectal est temporairement indisponible.

Pages